Bevacizumab and Chemotherapy for Recurrent Glioblastoma: A Single-Institution Experience

Neurology - United States
doi 10.1212/01.wnl.0000345668.03039.90
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy